NewGenIvf Group Limited (NIVF)

NewGenIvf Group Statistics

Total Valuation

NewGenIvf Group has a market cap or net worth of $643,054. The enterprise value is $2.14 million.

Market Cap	643,054
Enterprise Value	2.14M

Important Dates

The next estimated earnings date is Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	n/a

Share Statistics

NewGenIvf Group has 1.32 million shares outstanding.

Current Share Class	1.32M
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+116.01%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	0.24%
Float	1.32M

Valuation Ratios

The trailing PE ratio is 0.00.

PE Ratio	0.00
Forward PE	n/a
PS Ratio	0.01
Forward PS	n/a
PB Ratio	0.01
P/TBV Ratio	0.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.12
EV / Sales	0.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.19.

Current Ratio	3.43
Quick Ratio	3.37
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.51

Financial Efficiency

Return on equity (ROE) is 160.54% and return on invested capital (ROIC) is -33.25%.

Return on Equity (ROE)	160.54%
Return on Assets (ROA)	-23.10%
Return on Invested Capital (ROIC)	-33.25%
Return on Capital Employed (ROCE)	-20.16%
Revenue Per Employee	$60,204
Profits Per Employee	$229,475
Employee Count	76
Asset Turnover	0.25
Inventory Turnover	39.66

Taxes

Income Tax	-486,706
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.97% in the last 52 weeks. The beta is -0.04, so NewGenIvf Group's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-99.97%
50-Day Moving Average	1.15
200-Day Moving Average	24.51
Relative Strength Index (RSI)	27.95
Average Volume (20 Days)	832,124

Short Selling Information

The latest short interest is 13,899, so 1.05% of the outstanding shares have been sold short.

Short Interest	13,899
Short Previous Month	223,462
Short % of Shares Out	1.05%
Short % of Float	1.06%
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, NewGenIvf Group had revenue of $4.58 million and earned $17.44 million in profits. Earnings per share was $127.60.

Revenue	4.58M
Gross Profit	970,956
Operating Income	-6.84M
Pretax Income	16.90M
Net Income	17.44M
EBITDA	-6.83M
EBIT	-6.84M
Earnings Per Share (EPS)	$127.60

Balance Sheet

The company has $3.92 million in cash and $5.50 million in debt, with a net cash position of -$1.58 million or -$1.20 per share.

Cash & Cash Equivalents	3.92M
Total Debt	5.50M
Net Cash	-1.58M
Net Cash Per Share	-$1.20
Equity (Book Value)	28.74M
Book Value Per Share	68.23
Working Capital	3.93M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 21.22%, with operating and profit margins of -149.54% and 381.16%.

Gross Margin	21.22%
Operating Margin	-149.54%
Pretax Margin	369.43%
Profit Margin	381.16%
EBITDA Margin	-149.21%
EBIT Margin	-149.54%
FCF Margin	n/a

Dividends & Yields

NewGenIvf Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3,150.64%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	167.43%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 1, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Dec 1, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

NewGenIvf Group has an Altman Z-Score of 0.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.63
Piotroski F-Score	3